InsidersTradesSigma
Follow the Biotron Limited share price and the full insider trade history of the company, a publicly traded company based in Australia. Shares are quoted on the AU market, under the authority of ASX. Operating in the Health Care sector, Biotron Limited has logged 2 reports. Market capitalisation: €5.6m. The latest transaction was filed on 18 August 2026 (Change in Substantial Holding). Among the most active insiders: There was a change in the interests of the. All data is openly available.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 August 2026
Declarations2 total
ShareASXISIN AU000000BIT4ASX:2924-03122352-2A1690152
ShareASXISIN AU000000BIT4ASX:2924-03090484-2A1672245
2 of 2 declarations
About Biotron Limited
Biotron Limited is an Australian biopharmaceutical company focused on developing treatments for viral diseases and immune disorders. It is listed on the Australian Securities Exchange (XASX).
